Program
Chorionic Gonadotropin
Also written as “hCG”, “HCG injection” and “Pregnyl: Human chorionic gonadotrophin”.
Its studies are mostly in Hypogonadism · Infertility · Infertility, Female, led by 3 companies.
Drug pageChorionic Gonadotropin: every studyAll 92 studies of it, academic ones too, with its approvals, label and forms.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Organonits history only | 20 open or running | phase 3since Oct 16, 2012 | Oct 16, 2012 | none ahead |
| Fertility Center of Las Vegasits history only | 11 open or running | phase 4since May 27, 2025 | May 27, 2025 | Dec 31, 2027phase 4 · NCT07004192 |
| Genuine Research Center, Egypt | 10 open or running | phase 4since Sep 22, 2020 | Sep 22, 2020 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Genuine Research Center, Egypt only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). An open circle marks the day WHO proposed its name. Dates ahead are the sponsors’ estimates.
- Dec 9, 2019Named chorionic gonadotropinINNProposed as its International Nonproprietary Name in WHO's List 122
- Sep 22, 2020First study: phase 4 study in Infertility, FemaleFirst studyNCT04605107 · 60 enrolled · Egypt
TargetBeta
“Luteinizing hormone/Choriogonadotropin receptor agonist”ChEMBL 37, by rule
Other programs on LHCGR
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| lutropin alfarule | Merck KGaA, Darmstadt, Germany | phase 4 | 9 |
Studies
The one study Genuine Research Center, Egypt leads. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT04605107Infertility, Female · Egypt | 4 | Completed | Jan 8, 2015 | 60 |
How it is read
Names in the registry
- “hCG”, 2 entries
- “HCG injection”, 1 entry
- “Pregnyl: Human chorionic gonadotrophin”, 1 entry
Conditions, from the studies’ own filings
- Hypogonadism, 2 studies
- Infertility, 1 study
- Infertility, Female, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.